WALTHAM, Mass.--(BUSINESS WIRE)--Aug. 30, 2006--Oscient Pharmaceuticals Corporation (Nasdaq: OSCI) will participate in the Thomas Weisel Healthcare Conference 2006 on September 6, 2006 in Boston, Massachusetts. President and CEO, Steven Rauscher, will provide an overview of the Company including details on the acquisition of ANTARA(R) 130 mg (fenofibrate) capsules and the recent sublicense of FACTIVE(R) (gemifloxacin mesylate) tablets in Canada to Abbott Canada.
